+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cells



Proteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cells



Plos one 7(7): E40820



Transforming growth factor-β1 (TGF-β1) induces the differentiation of human adipose tissue-derived mesenchymal stem cells (hASCs) into smooth muscle cells. Lipid rafts are cholesterol-rich microdomains in cell membranes that reportedly play a key role in receptor-mediated signal transduction and cellular responses. In order to clarify whether lipid rafts are involved in TGF-β1-induced differentiation of hASCs into smooth muscle cells, we analyzed the lipid raft proteome of hASCs. Pretreatment of hASCs with the lipid raft disruptor methyl-β-cyclodextrin abrogated TGF-β1-induced expression of α-smooth muscle actin, a smooth muscle cell marker, suggesting a pivotal role of lipid rafts in TGF-β1-induced differentiation of hASCs to smooth muscle cells. Sucrose density gradient centrifugation along with a shotgun proteomic strategy using liquid chromatography-tandem mass spectrometry identified 1002 individual proteins as the lipid raft proteome, and 242 of these were induced by TGF-β1 treatment. ADAM12, a disintegrin and metalloproteases family member, was identified as the most highly up-regulated protein in response to TGF-β1 treatment. TGF-β1 treatment of hASCs stimulated the production of both ADAM12 protein and mRNA. Silencing of endogenous ADAM12 expression using lentiviral small hairpin RNA or small interfering RNA abrogated the TGF-β1-induced differentiation of hASCs into smooth muscle cells. These results suggest a pivotal role for lipid raft-associated ADAM12 in the TGF-β1-induced differentiation of hASCs into smooth muscle cells.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055257292

Download citation: RISBibTeXText

PMID: 22808268


Related references

Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cells. Molecular Biology of the Cell 25(25): 4106-4114, 2014

Experimental study of differentiation of umbilical cord mesenchymal stem cells into smooth muscle cells induced by bladder smooth muscle cells conditioned medium. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 27(12): 1506-1511, 2013

Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells. Experimental and Molecular Medicine 44(2): 159-166, 2012

A novel method for differentiation of human mesenchymal stem cells into smooth muscle-like cells on clinically deliverable thermally induced phase separation microspheres. Tissue Engineering. Part C Methods 21(4): 404-412, 2015

Simulated uterus microenvironment induced human placental mesenchymal stem cells differentiation to uterus smooth muscle cells in vitro. Zhonghua Yi Xue Za Zhi 88(45): 3200-3204, 2008

O1049 Simulated uterus microenvironment induced human placental mesenchymal stem cells differentiation to uterus smooth muscle cells in vitro. International Journal of Gynecology & Obstetrics 107: S391-S392, 2009

Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. International Journal of Biochemistry and Cell Biology 40(11): 2482-2491, 2008

Human endothelial progenitor cells induce extracellular signal-regulated kinase-dependent differentiation of mesenchymal stem cells into smooth muscle cells upon cocultivation. Tissue Engineering. Part a 18(23-24): 2395-2405, 2012

Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth muscle-like cells. Stem Cells 27(1): 191-199, 2008

MicroRNA-145-based differentiation of human mesenchymal stem cells to smooth muscle cells. Biotechnology Letters 38(11): 1975-1981, 2016

Evaluation of mechanical properties of human mesenchymal stem cells during differentiation to smooth muscle cells. Annals of Biomedical Engineering 42(7): 1373-1380, 2014

Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-(Sb(B-dependent mechanism. Journal of cell science1 119(23): 4994-5005, 2006

Influence of micropattern width on differentiation of human mesenchymal stem cells to vascular smooth muscle cells. Colloids and Surfaces. B Biointerfaces 122: 316-323, 2014

Human models for smooth muscle cell differentiation. Focus on "A novel in vitro model system for smooth muscle differentiation from human embryonic stem cell-derived mesenchymal cells". American Journal of Physiology. Cell Physiology 304(4): C287-C288, 2013

Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. Journal of Cell Science 119(Pt 23): 4994-5005, 2006